Pharsight

Drugs that contain Tamoxifen Citrate

1. Soltamox patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6127425 MAYNE PHARMA COMMRCL Oral liquid medicine solution
Jun, 2018

(5 years ago)

Market Authorisation Date: 29 October, 2005

Treatment: NA

Dosage: SOLUTION;ORAL

More Information on Dosage

SOLTAMOX family patents

Family Patents